Study of New Adjuvant Chemotherapy of Non Resectable Liver Metastasis of Colorectal Cancer Without Bleeding, Obstruction
Interventional
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
liver metastasis resection rate
3 years
Yes
China: Food and Drug Administration
20110101
NCT01307878
January 2011
December 2015
Name | Location |
---|